Cargando…
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo
BACKGROUND: Chemotherapy in cancer patients can be associated with serious short- and long-term adverse neurological effects, such as leukoencephalopathy and cognitive impairment, even when therapy is delivered systemically. The underlying cellular basis for these adverse effects is poorly understoo...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2000477/ https://www.ncbi.nlm.nih.gov/pubmed/17125495 http://dx.doi.org/10.1186/jbiol50 |